View Cart (0 items)


EU, US health officials team up to fight antimicrobial resistance

May 19, 2014
Health officials from both sides of the Atlantic have been working together to tackle antimicrobial resistance under their joint Transatlantic Taskforce on Antimicrobial Resistance.
Read More

Bayer to take over Merck's consumer care business in $14.2 billion deal

May 13, 2014
German pharmaceutical giant Bayer is acquiring the over-the-counter medicines business of U.S. rival Merck & Co., Inc.
Read More

Sanofi looking to shed multi-billion portfolio to optimize assets

May 6, 2014
French pharmaceutical giant Sanofi SA is exploring options to sell a range of older drugs, with an estimated value of the portfolio between $7 billion and $8 billion.
Read More

US wholesale sector consolidation hits Indian drug makers

April 30, 2014
The U.S. pharmaceutical sector is going through a period of consolidation and this has already has a noticeable effect on Indian drug makers.
Read More

Pfizer proposes $101 billion takeover to AstraZeneca, reports claim

April 28, 2014
U.S. pharmaceutical company Pfizer has expressed interest in taking over Anglo-Swedish giant AstraZeneca for a total of $101 billion.
Read More

Lupin recalls 9,000 bottles of antibiotic drug

April 21, 2014
Two lots of Suprax, an antibiotic drug used to treat bacterial infections, are being withdrawn from the U.S. market because the product does not meet federal standards for impurities.
Read More

US, EU generic drug makers call for regulatory cooperation

April 16, 2014
Generic pharmaceuticals manufacturers from Europe and the United States have urged regulators on both sides of the Atlantic to adopt a strategy of "regulatory convergence."
Read More

Scientists find benefits of Tamiflu overestimated

April 14, 2014
A new study raises concerns that the effect of the vastly popular influenza treatment drug may have been overestimated.
Read More

Teva's application for patent extension on Copaxone rejected

April 8, 2014
The U.S. Patent and Trademark Office has rejected the request from Israeli pharma giant Teva Pharmaceuticals to have its patent protection on Copaxone extended until September 2015.
Read More

US demand for pharma excipients to rise 4.3% per year through 2018

April 3, 2014
Excipients in oral formulations, such as tablets and capsules, will be well positioned for strong market performance.
Read More